105 related articles for article (PubMed ID: 9565135)
41. Differential modulation of alpha2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment.
Callado LF; Gabilondo AM; Meana JJ
Life Sci; 1999; 64(25):2327-39. PubMed ID: 10374896
[TBL] [Abstract][Full Text] [Related]
42. Characterization of a new radioiodinated probe for the alpha2C adrenoceptor in the mouse brain.
Dossin O; Moulédous L; Baudry X; Tafani JA; Mazarguil H; Zajac JM
Neurochem Int; 2000 Jan; 36(1):7-18. PubMed ID: 10566954
[TBL] [Abstract][Full Text] [Related]
43. Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain.
Petrash AC; Bylund DB
Life Sci; 1986 Jun; 38(23):2129-37. PubMed ID: 3012234
[TBL] [Abstract][Full Text] [Related]
44. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
Renouard A; Widdowson PS; Millan MJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
[TBL] [Abstract][Full Text] [Related]
45. Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectively of antagonist binding.
Marjamäki A; Luomala K; Ala-Uotila S; Scheinin M
Eur J Pharmacol; 1993 Aug; 246(3):219-26. PubMed ID: 7901041
[TBL] [Abstract][Full Text] [Related]
46. Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.
Scheibner J; Trendelenburg AU; Hein L; Starke K
Br J Pharmacol; 2001 Feb; 132(4):925-33. PubMed ID: 11181434
[TBL] [Abstract][Full Text] [Related]
47. Characterization of alpha2 adrenergic receptor subtypes in human ocular tissue homogenates.
Bylund DB; Chacko DM
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2299-306. PubMed ID: 10476796
[TBL] [Abstract][Full Text] [Related]
48. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
49. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
[TBL] [Abstract][Full Text] [Related]
50. Alpha-1 adrenergic receptor: binding and phosphoinositide breakdown in human myometrium.
Breuiller-Fouche M; Doualla-Bell Kotto Maka F; Geny B; Ferre F
J Pharmacol Exp Ther; 1991 Jul; 258(1):82-7. PubMed ID: 1649302
[TBL] [Abstract][Full Text] [Related]
51. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
52. Alpha-2 adrenoceptors on nerves and muscles of rat uterus.
Kyozuka M; Crankshaw DJ; Crankshaw J; Berezin I; Kwan CY; Daniel EE
J Pharmacol Exp Ther; 1988 Mar; 244(3):1128-38. PubMed ID: 2855241
[TBL] [Abstract][Full Text] [Related]
53. Specific role of α2A - and α2B -, but not α2C -, adrenoceptor subtypes in the inhibition of the vasopressor sympathetic out-flow in diabetic pithed rats.
Altamirano-Espinoza AH; Manrique-Maldonado G; Marichal-Cancino BA; Villalón CM
Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):31-8. PubMed ID: 25407049
[TBL] [Abstract][Full Text] [Related]
54. Heterogeneous expression of alpha 1-adrenoceptor subtypes among rat nephron segments.
Feng F; Abel PW; Scofield M; Liu F; Wolff DW; Jeffries WB
Mol Pharmacol; 1993 Nov; 44(5):926-33. PubMed ID: 8246915
[TBL] [Abstract][Full Text] [Related]
55. The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Oct; 10(5):e01003. PubMed ID: 36101495
[TBL] [Abstract][Full Text] [Related]
56. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype.
Bylund DB; Ray-Prenger C; Murphy TJ
J Pharmacol Exp Ther; 1988 May; 245(2):600-7. PubMed ID: 2835476
[TBL] [Abstract][Full Text] [Related]
57. The role of alpha-2 adrenoceptor subtype in the antiallodynic effect of intraplantar dexmedetomidine in a rat spinal nerve ligation model.
Lee HG; Choi JI; Kim YO; Yoon MH
Neurosci Lett; 2013 Dec; 557 Pt B():118-22. PubMed ID: 24161890
[TBL] [Abstract][Full Text] [Related]
58. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep.
Schwartz DD; Clark TP
J Vet Pharmacol Ther; 1998 Oct; 21(5):342-7. PubMed ID: 9811433
[TBL] [Abstract][Full Text] [Related]
59. Expression of two alpha 2-adrenergic receptor subtypes in human placenta: evidence from direct binding studies.
Falkay G; Kovács L
Placenta; 1994 Sep; 15(6):661-8. PubMed ID: 7824451
[TBL] [Abstract][Full Text] [Related]
60. Beta-adrenergic receptor subtype gene expression in timed-pregnant rat myometrium.
Principe D; Sanseverino M; Saunders T; Phillippe M
Am J Obstet Gynecol; 1997 Feb; 176(2):349-57. PubMed ID: 9065180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
